207 related articles for article (PubMed ID: 25952334)
21. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications.
Bartzokis G; Lu PH; Tishler TA; Fong SM; Oluwadara B; Finn JP; Huang D; Bordelon Y; Mintz J; Perlman S
Neurochem Res; 2007 Oct; 32(10):1655-64. PubMed ID: 17484051
[TBL] [Abstract][Full Text] [Related]
22. The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study.
Sánchez-Castañeda C; Squitieri F; Di Paola M; Dayan M; Petrollini M; Sabatini U
Hum Brain Mapp; 2015 Jan; 36(1):50-66. PubMed ID: 25145324
[TBL] [Abstract][Full Text] [Related]
23. Alterations in brain transition metals in Huntington disease: an evolving and intricate story.
Rosas HD; Chen YI; Doros G; Salat DH; Chen NK; Kwong KK; Bush A; Fox J; Hersch SM
Arch Neurol; 2012 Jul; 69(7):887-93. PubMed ID: 22393169
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal change in basal ganglia volume in patients with Huntington's disease.
Aylward EH; Li Q; Stine OC; Ranen N; Sherr M; Barta PE; Bylsma FW; Pearlson GD; Ross CA
Neurology; 1997 Feb; 48(2):394-9. PubMed ID: 9040728
[TBL] [Abstract][Full Text] [Related]
25. Texture analysis of ultrahigh field T2*-weighted MR images of the brain: application to Huntington's disease.
Doan NT; van den Bogaard SJ; Dumas EM; Webb AG; van Buchem MA; Roos RA; van der Grond J; Reiber JH; Milles J
J Magn Reson Imaging; 2014 Mar; 39(3):633-40. PubMed ID: 23723108
[TBL] [Abstract][Full Text] [Related]
26. The role of iron imaging in Huntington's disease.
van den Bogaard SJ; Dumas EM; Roos RA
Int Rev Neurobiol; 2013; 110():241-50. PubMed ID: 24209441
[TBL] [Abstract][Full Text] [Related]
27. Diffusion-weighted imaging in Huntington's disease.
Seppi K; Schocke MF; Mair KJ; Esterhammer R; Weirich-Schwaiger H; Utermann B; Egger K; Brenneis C; Granata R; Boesch S; Poewe W; Wenning GK
Mov Disord; 2006 Jul; 21(7):1043-7. PubMed ID: 16570300
[TBL] [Abstract][Full Text] [Related]
28. Structural Magnetic Resonance Imaging in Huntington's Disease.
Wilson H; Dervenoulas G; Politis M
Int Rev Neurobiol; 2018; 142():335-380. PubMed ID: 30409258
[TBL] [Abstract][Full Text] [Related]
29. Postural limits of stability in premanifest and manifest Huntington's disease.
Medina LD; Pirogovsky E; Salomonczyk D; Goldstein J; Panzera R; Gluhm S; Simmons R; Corey-Bloom J; Gilbert PE
J Huntingtons Dis; 2013; 2(2):177-84. PubMed ID: 25063514
[TBL] [Abstract][Full Text] [Related]
30. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
[TBL] [Abstract][Full Text] [Related]
31. Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.
Georgiou-Karistianis N; Poudel GR; Domínguez D JF; Langmaid R; Gray MA; Churchyard A; Chua P; Borowsky B; Egan GF; Stout JC
Brain Cogn; 2013 Oct; 83(1):80-91. PubMed ID: 23938592
[TBL] [Abstract][Full Text] [Related]
32. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.
Shin C; Lee S; Lee JY; Rhim JH; Park SW
J Korean Med Sci; 2018 Mar; 33(13):e96. PubMed ID: 29573246
[TBL] [Abstract][Full Text] [Related]
33. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease.
van Bergen JM; Hua J; Unschuld PG; Lim IA; Jones CK; Margolis RL; Ross CA; van Zijl PC; Li X
AJNR Am J Neuroradiol; 2016 May; 37(5):789-96. PubMed ID: 26680466
[TBL] [Abstract][Full Text] [Related]
35. Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
Russell DS; Jennings DL; Barret O; Tamagnan GD; Carroll VM; Caillé F; Alagille D; Morley TJ; Papin C; Seibyl JP; Marek KL
Neurology; 2016 Feb; 86(8):748-54. PubMed ID: 26802091
[TBL] [Abstract][Full Text] [Related]
36. Age-related iron deposition in the basal ganglia of controls and Alzheimer disease patients quantified using susceptibility weighted imaging.
Wang D; Li YY; Luo JH; Li YH
Arch Gerontol Geriatr; 2014; 59(2):439-49. PubMed ID: 24820446
[TBL] [Abstract][Full Text] [Related]
37. Cortical inhibitory deficits in premanifest and early Huntington's disease.
Philpott AL; Cummins TDR; Bailey NW; Churchyard A; Fitzgerald PB; Georgiou-Karistianis N
Behav Brain Res; 2016 Jan; 296():311-317. PubMed ID: 26416671
[TBL] [Abstract][Full Text] [Related]
38. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.
Majid DS; Aron AR; Thompson W; Sheldon S; Hamza S; Stoffers D; Holland D; Goldstein J; Corey-Bloom J; Dale AM
Mov Disord; 2011 Dec; 26(14):2544-51. PubMed ID: 21932302
[TBL] [Abstract][Full Text] [Related]
39. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease.
Saft C; Schüttke A; Beste C; Andrich J; Heindel W; Pfleiderer B
Neuropsychologia; 2008 Apr; 46(5):1279-89. PubMed ID: 18221758
[TBL] [Abstract][Full Text] [Related]
40. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
